|
C9ORF40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63539999997742E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.59590000395838E-08 |
| Normal-vs-Stage2 |
2.121200E-01 |
| Normal-vs-Stage3 |
5.292000E-01 |
| Normal-vs-Stage4 |
5.661200E-01 |
| Stage1-vs-Stage2 |
1.437180E-01 |
| Stage1-vs-Stage3 |
1.741910E-02 |
| Stage1-vs-Stage4 |
7.336000E-03 |
| Stage2-vs-Stage3 |
6.165800E-01 |
| Stage2-vs-Stage4 |
2.056000E-01 |
| Stage3-vs-Stage4 |
3.838600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.71900000292646E-08 |
| Normal-vs-AfricanAmerican |
1.871180E-01 |
| Normal-vs-Asian |
6.382200E-01 |
| Caucasian-vs-AfricanAmerican |
9.520100E-02 |
| Caucasian-vs-Asian |
1.939970E-01 |
| AfricanAmerican-vs-Asian |
3.629200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03959998784842E-09 |
| Normal-vs-Female |
4.901400E-01 |
| Male-vs-Female |
7.718100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.346170E-01 |
| Normal-vs-Extreme_Weight |
5.77960002079436E-09 |
| Normal-vs-Obese |
6.959600E-02 |
| Normal-vs-Extreme_Obese |
3.677200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.887800E-02 |
| Normal_Weight-vs-Obese |
9.443800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.488200E-01 |
| Extreme_Weight-vs-Obese |
6.148200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.878000E-01 |
| Obese-vs-Extreme_Obese |
9.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.661600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.20620000000494E-05 |
| Normal-vs-Age(61-80Yrs) |
2.11589999998818E-06 |
| Normal-vs-Age(81-100Yrs) |
3.50100000001685E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.072960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.147700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.803900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.080600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.178600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.057400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.07300012897849E-10 |
| Normal-VS-Type2 PRCC |
2.249900E-02 |
| Normal-VS-KIRP CIMP |
6.370100E-04 |
| Normal-VS-Unclassified PRCC |
8.3917000015532E-08 |
| Type1 PRCC-VS-Type2 PRCC |
9.461700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.69600000000148E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.832800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.03700000031459E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
3.854200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.924700000002E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99649000000024E-05 |
| Normal-vs-N1 |
3.251400E-01 |
| Normal-vs-N2 |
9.803200E-01 |
| N0-vs-N1 |
9.821400E-03 |
| N0-vs-N2 |
1.670400E-01 |
| N1-vs-N2 |
6.787800E-01 |
|
|
